Begin by reading and reviewing the Biocon Market Sizing Case Study Analysis, found here using this link:

https://www.coursehero.com/u/file/197382724/Biocon-Launching-a-New-Cancer-Drug-in-India-Casepdf/

Then give a thorough analysis and answer the following:

1. Assuming Biocon receives approval for BIOMAb, should it launch the drug immediately or conduct phase 3 trials before launch?
2. Discuss the pros and cons relative to your chosen market entry strategy.
3. What is the TAM SAM SOM for Biocon at the time of entry you have selected?
4. Forecast the market size for Biocon at the end of five years. What assumptions did you make in your forecast?
5. What price should be set for Biocon? Is this the price per dose or total treatment with Biocon?
6. What information does your team need for the TAM SAM SOM analysis?